Another study employing a murine model of pneumonia caused by MRSA found that mice with CD80- and CD86-deficiency had significant reductions in pro-inflammatory cytokine levels and had significantly improved survival rates, corroborating the hypothesis that attenuation of inflammation in infectious conditions minimizes damage and promotes recovery26. This evidence concerns the gene CD86 and pneumonia.